Healthcare provider profile · identity verified

William A Nitardy, MD

Internal Medicine · CINCINNATI, OH · NPI 1083829923

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	607	131
Atorvastatin Calcium	Atorvastatin Calcium	592	129
Lisinopril	Lisinopril	351	79
Losartan Potassium	Losartan Potassium	286	64
Omeprazole	Omeprazole	280	60
Hydrochlorothiazide	Hydrochlorothiazide	251	58
Metformin Hcl	Metformin Hcl	243	61
Albuterol Sulfate Hfa	Albuterol Sulfate	240	53
Gabapentin	Gabapentin	218	44
Metoprolol Succinate	Metoprolol Succinate	172	29
Levothyroxine Sodium	Levothyroxine Sodium	159	30
Metoprolol Tartrate	Metoprolol Tartrate	159	29
Pantoprazole Sodium	Pantoprazole Sodium	157	38
Fluticasone Propionate	Fluticasone Propionate	151	46
Eliquis	Apixaban	130	20
Trulicity	Dulaglutide	107	19
Sertraline Hcl	Sertraline Hcl	106	19
Meloxicam	Meloxicam	103	19
Potassium Chloride	Potassium Chloride	100	19
Famotidine	Famotidine	94	20
Ozempic	Semaglutide	92	17
Trazodone Hcl	Trazodone Hcl	84	16
Zolpidem Tartrate	Zolpidem Tartrate	83	13
Jardiance	Empagliflozin	82	17
Nifedipine Er	Nifedipine	80	17
Rosuvastatin Calcium	Rosuvastatin Calcium	76	23
Furosemide	Furosemide	71	21
Montelukast Sodium	Montelukast Sodium	65	14
Clopidogrel	Clopidogrel Bisulfate	64	17
Metformin Hcl Er	Metformin Hcl	64	18
Amitriptyline Hcl	Amitriptyline Hcl	63	14
Oxybutynin Chloride Er	Oxybutynin Chloride	63	13
Carvedilol	Carvedilol	62	14
Hydroxyzine Hcl	Hydroxyzine Hcl	60	14
Fluoxetine Hcl	Fluoxetine Hcl	59	12
Valsartan	Valsartan	59	15
Methocarbamol	Methocarbamol	57	21
Quetiapine Fumarate	Quetiapine Fumarate	57	suppressed
Warfarin Sodium	Warfarin Sodium	57	12
Allopurinol	Allopurinol	55	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	54	11
Citalopram Hbr	Citalopram Hydrobromide	54	suppressed
Tramadol Hcl	Tramadol Hcl	54	13
Buspirone Hcl	Buspirone Hcl	53	suppressed
Duloxetine Hcl	Duloxetine Hcl	53	12
Bupropion Xl	Bupropion Hcl	52	suppressed
Ibuprofen	Ibuprofen	49	12
Pravastatin Sodium	Pravastatin Sodium	47	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	15
Atenolol	Atenolol	43	11
Prednisone	Prednisone	42	18
Lidocaine	Lidocaine	41	suppressed
Ventolin Hfa	Albuterol Sulfate	41	suppressed
Diclofenac Sodium	Diclofenac Sodium	40	15
Mupirocin	Mupirocin	39	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	suppressed
Ondansetron Hcl	Ondansetron Hcl	38	suppressed
Xarelto	Rivaroxaban	38	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	37	14
Mirtazapine	Mirtazapine	37	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	36	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	35	13
Tizanidine Hcl	Tizanidine Hcl	35	suppressed
Clonazepam	Clonazepam	34	suppressed
Spironolactone	Spironolactone	34	suppressed
Risperidone	Risperidone	32	suppressed
Incruse Ellipta	Umeclidinium Bromide	30	suppressed
Baclofen	Baclofen	29	suppressed
Hydrocortisone	Hydrocortisone	29	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Klor-Con M20	Potassium Chloride	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Simvastatin	Simvastatin	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	25
Naproxen	Naproxen	26	11
Doxycycline Hyclate	Doxycycline Hyclate	25	23
Ezetimibe	Ezetimibe	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Promethazine Hcl	Promethazine Hcl	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Loperamide	Loperamide Hcl	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Finasteride	Finasteride	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Arnuity Ellipta	Fluticasone Furoate	20	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Clotrimazole	Clotrimazole	19	suppressed
Glipizide	Glipizide	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Colchicine	Colchicine	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Fluconazole	Fluconazole	18	12
Glipizide Er	Glipizide	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Torsemide	Torsemide	17	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Fentanyl	Fentanyl	15	suppressed
Xifaxan	Rifaximin	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Topiramate	Topiramate	13	suppressed
Humulin R	Insulin Regular, Human	12	suppressed
Nystop	Nystatin	12	suppressed
Sf 5000 Plus	Fluoride (Sodium)	12	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Zonisamide	Zonisamide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error